The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: Brisbane-based drug discovery and development company Alchemia has been granted a key US patent critical to ...
Singapore: A panel of experts at the Health, Labor and Welfare Ministry of Japan will start producing a vaccine for the ...
Singapore: Daiichi Sankyo's animal vaccine unit, Kitasato Daiichi Sankyo Vaccine is discontinuing its animal vaccine bus...
Singapore: Global ophthalmic company OptiMedica has expanded international market adoption of its Catalys Precision Las...
Singapore: WaferGen Bio-systems announced a co-marketing agreement with Qiagen for the promotion of certain products in ...
Singapore: Novartis has announced that the European Commission has approved once-daily Ultibro Breezhaler (indacaterol 8...
With a view of expanding their customer base, Shimadzu Analytical India has been taking concrete steps towards connectin...
Singapore: Japan's Takeda Pharmaceutical has promoted Mr Christophe Weber, representative director, president and chief ...
Singapore: Millennium: The Takeda Oncology Company, has initiated an international phase III clinical trial evaluating M...
Singapore: Japan-based drugmaker Astellas Pharma is planning to sell its dermatology portfolio, which could be worth bet...
Singapore: Japan-headquartered SymBio Pharmaceuticals has completed patient enrollment for its phase II clinical trial o...
Singapore: OMRON Corporation reported consolidated performance for the first quarter (Q1) of fiscal 2012, which included...
Singapore: The Tomato Genome Consortium (TGC), which is a group of over 300 scientists from 13 countries sequenced the g...
Singapore: Japan-based Nitto Denko announced that Toa Eiyo has received manufacturing and marketing authorization in Jap...
Singapore: Eisai and Toyama Chemical have received approval from Japan's Ministry of Health, Labour and Welfare to marke...
Singapore: Daiichi Sankyo submitted an application for a partial label change in Japan to manufacture and market the inf...
Singapore: The FDA had during September 2012 informed Shionogi that it need to conduct two clinical trials in order to e...
